Cargando…

Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations

Background: In patients with diabetes, transplantation of stem cells increases C-peptide levels and induces insulin independence for some period. Today, this positive therapeutic outcome is widely attributed to the well-documented immunomodulatory properties of stem cells. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Tootee, Ali, Nikbin, Behrouz, Nasli Esfahani, Ensieh, Arjmand, Babak, Aghayan, Hamidreza, Qorbani, Mostafa, Ghahari, Aziz, Larijani, Bagher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448473/
https://www.ncbi.nlm.nih.gov/pubmed/36128298
http://dx.doi.org/10.47176/mjiri.36.34
_version_ 1784784069594185728
author Tootee, Ali
Nikbin, Behrouz
Nasli Esfahani, Ensieh
Arjmand, Babak
Aghayan, Hamidreza
Qorbani, Mostafa
Ghahari, Aziz
Larijani, Bagher
author_facet Tootee, Ali
Nikbin, Behrouz
Nasli Esfahani, Ensieh
Arjmand, Babak
Aghayan, Hamidreza
Qorbani, Mostafa
Ghahari, Aziz
Larijani, Bagher
author_sort Tootee, Ali
collection PubMed
description Background: In patients with diabetes, transplantation of stem cells increases C-peptide levels and induces insulin independence for some period. Today, this positive therapeutic outcome is widely attributed to the well-documented immunomodulatory properties of stem cells. The aim of this study was to report alternations (the trend of increase or decrease) in different lymphocyte populations in a stem cell clinical trial performed in our institute. Methods: Recorded data of a clinical trial conducted on 72 patients with type 1 diabetes who had received fetal stem cell transplantation several years ago and were regularly monitored before and after the procedure in 1, 3, 6, 12, 24 months were analyzed. In these regular follow-up visits, insulin demand, HbA1c, C-peptide, and alternation to B cell and T cell populations were analyzed and recorded. For the purpose of the current study, patients were retrospectively divided into 2 groups, namely, those with the positive response to treatment and patients without such response. Temporary positive therapeutic response was defined by 2 different indicators, namely, plasma C-peptide levels and insulin dose-adjusted A1C (IDAA1c), which was calculated as A1C (percent) + (4 × insulin dose (units per kilogram per 24 h). Data analysis was performed by means of SPSS Version 18. Results: Besides the short-term therapeutic effect, we observed remarkably significant alternations to the populations of B and T lymphocytes in the recipients. When patients were retrospectively assigned to 2 different groups of patients with a positive therapeutic response (based on C-peptide changes) and those without it, it was observed that alternations to different populations of B-cells and T-cells were significantly different in these 2 groups. Conclusion: Our results demonstrated that transplantation of stem cells leads to significant positive therapeutic outcomes in one group of patients who showed totally distinct patterns of alternation to different groups of lymphocytes.
format Online
Article
Text
id pubmed-9448473
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-94484732022-09-19 Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations Tootee, Ali Nikbin, Behrouz Nasli Esfahani, Ensieh Arjmand, Babak Aghayan, Hamidreza Qorbani, Mostafa Ghahari, Aziz Larijani, Bagher Med J Islam Repub Iran Original Article Background: In patients with diabetes, transplantation of stem cells increases C-peptide levels and induces insulin independence for some period. Today, this positive therapeutic outcome is widely attributed to the well-documented immunomodulatory properties of stem cells. The aim of this study was to report alternations (the trend of increase or decrease) in different lymphocyte populations in a stem cell clinical trial performed in our institute. Methods: Recorded data of a clinical trial conducted on 72 patients with type 1 diabetes who had received fetal stem cell transplantation several years ago and were regularly monitored before and after the procedure in 1, 3, 6, 12, 24 months were analyzed. In these regular follow-up visits, insulin demand, HbA1c, C-peptide, and alternation to B cell and T cell populations were analyzed and recorded. For the purpose of the current study, patients were retrospectively divided into 2 groups, namely, those with the positive response to treatment and patients without such response. Temporary positive therapeutic response was defined by 2 different indicators, namely, plasma C-peptide levels and insulin dose-adjusted A1C (IDAA1c), which was calculated as A1C (percent) + (4 × insulin dose (units per kilogram per 24 h). Data analysis was performed by means of SPSS Version 18. Results: Besides the short-term therapeutic effect, we observed remarkably significant alternations to the populations of B and T lymphocytes in the recipients. When patients were retrospectively assigned to 2 different groups of patients with a positive therapeutic response (based on C-peptide changes) and those without it, it was observed that alternations to different populations of B-cells and T-cells were significantly different in these 2 groups. Conclusion: Our results demonstrated that transplantation of stem cells leads to significant positive therapeutic outcomes in one group of patients who showed totally distinct patterns of alternation to different groups of lymphocytes. Iran University of Medical Sciences 2022-04-13 /pmc/articles/PMC9448473/ /pubmed/36128298 http://dx.doi.org/10.47176/mjiri.36.34 Text en © 2022 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc-sa/1.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Tootee, Ali
Nikbin, Behrouz
Nasli Esfahani, Ensieh
Arjmand, Babak
Aghayan, Hamidreza
Qorbani, Mostafa
Ghahari, Aziz
Larijani, Bagher
Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title_full Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title_fullStr Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title_full_unstemmed Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title_short Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
title_sort clinical outcomes of fetal stem cell transplantation in type 1 diabetes are related to alternations to different lymphocyte populations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448473/
https://www.ncbi.nlm.nih.gov/pubmed/36128298
http://dx.doi.org/10.47176/mjiri.36.34
work_keys_str_mv AT tooteeali clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT nikbinbehrouz clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT nasliesfahaniensieh clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT arjmandbabak clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT aghayanhamidreza clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT qorbanimostafa clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT ghahariaziz clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations
AT larijanibagher clinicaloutcomesoffetalstemcelltransplantationintype1diabetesarerelatedtoalternationstodifferentlymphocytepopulations